Andrew Huberman· PhD
So it's 0 cost. And it involves no manipulation of brain neuromodulators or chemistry through pharmacology. So it's something that you can explore very safely and certainly not having to purchase anything.
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
So it's 0 cost. And it involves no manipulation of brain neuromodulators or chemistry through pharmacology. So it's something that you can explore very safely and certainly not having to purchase anything.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
There's a very exciting nonpharmacological tool. A purely behavioral tool that the research literature has told us can selectively increase dopamine within the nigrostriatal pathway. The pathway that's involved in divergent thinking. And can do so very dramatically as much as 65% above baseline.
And I'll tell you right now, that is the brain circuit that is engaged when you undergo divergent thinking.